PERTH: CardieX Limited’s subsidiary ATCOR has entered a co-development and commercial partnership agreement with Shenzen Stock Exchange listed company, Andon, one of China’s largest manufacturers of home-use medical electronic devices.
The three-year co-development and commercialization agreement with Andon provides for the development and commercialization of new medical and consumer health devices for home-use based on ATCOR’s patented and global standard SphygmoCor technology for measuring central blood pressure and arterial stiffness.
The first device under the Agreement to be named ATCOR “Pulse” (the Device) and will be targeted for commercial launch in the US, Europe, Australia and China in Q4 2021. ATCOR “Pulse” will be the first new medical device for ATCOR since 2012 and represents a game changing medical technology collaboration for home-use vital signs monitoring. This unique device will be the world’s first cloud-connected home-use BP monitor to include ATCOR’s SphygmoCor technology and Arty, ATCOR’s new cardiovascular vital signs and tele health platform.
The agreement with Andon in conjunction with the ATCOR “Pulse” device significantly expands the commercial market opportunity for CardieX into the home consumer health device market, which is estimated to be worth $US2.5 billion annually.
Craig Cooper, CEO & Managing Director of CardieX commented: “This is the most significant announcement of the Company’s evolution since I became CEO and represents a major value milestone for all shareholders. We now have the foundations of a fully developed ecosystem of home-health devices, digital health & telehealth solutions, wearable partnerships, and a remote patient monitoring platform -each of which target significant health-tech market opportunities -and each based on our patented SphygmoCor technology. Going forward we will continue to expand our product portfolio with new devices including new partnerships in medical and clinician based vital signs monitoring, wearables, and other health technologies”.
Mr Wang Yong, Vice President at Andon commented:”We are very excited to partner with ATCOR to develop the world’s first cloud-connected home-use blood pressure monitor with central blood pressure measurement capabilities. In the face of current healthcare needs, this kind of next-generation technology for more personalized cardiovascular health management is even more necessary”.
CardieX is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders.
Tianjin Jiu An Medical Electronics Co., Ltd., also known as Andon Health, is one of the largest home-use healthcare electronics manufacturers in China, specializing in R&D, production and commercialization of home healthcare products as well as health management cloud platform and services.
Leave a Reply